Research Center 23 — Jefferson City, Missouri

Research Center 23 is a clinical research site located in Jefferson City, Missouri, United States 65109.

Crixeo Clinical Trials Trust Score: 9/100 (FAILING). This profile has not yet been claimed by the site owner.

Research Center 23 has participated in 1 clinical trials with 1 currently active.

Therapeutic areas: Severe Hypertriglyceridemia.

Sponsors: Arrowhead Pharmaceuticals.

Is this your site?

Is this your site? Claim your profile and control the information sponsors and patients see.

Other research sites in Jefferson City

Browse all research sites in Missouri · View every site in Jefferson City

• SSM Health St. Mary's Hospital - Jefferson City
• Capital Region Hospital
• MU Health Care Goldschmidt Cancer Center
• Capital Region Southwest Campus
• Capital Region Medical Center-Goldschmidt Cancer Center
• Jefferson City Medical Group
• Goldschmidt Cancer Center
• Novo Nordisk Investigational Site
• GSK Investigational Site
• Pfizer Investigational Site
• Research Site
• Capitol Comprehensive Cancer Care Clinic

Sponsor Feasibility Report

Trust Score: 9/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Research Center 23?

Research Center 23 has a Crixeo Trust Score of 9/100 (FAILING). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Research Center 23 conducted?

Research Center 23 has 1 clinical trials on record, with 1 currently active. Their work covers Severe Hypertriglyceridemia.

Is Research Center 23 accredited by Crixeo Clinical Trials?

Research Center 23 has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Research Center 23?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.